Cargando…

Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study

BACKGROUND: Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ching-Hsin, Lin, Tzu-Ping, Chang, Yen-Hwa, Huang, William JS, Lin, Alex TL, Chen, Kuang-Kuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438483/
https://www.ncbi.nlm.nih.gov/pubmed/25956819
http://dx.doi.org/10.1186/s12894-015-0032-7
_version_ 1782372341625389056
author Chang, Ching-Hsin
Lin, Tzu-Ping
Chang, Yen-Hwa
Huang, William JS
Lin, Alex TL
Chen, Kuang-Kuo
author_facet Chang, Ching-Hsin
Lin, Tzu-Ping
Chang, Yen-Hwa
Huang, William JS
Lin, Alex TL
Chen, Kuang-Kuo
author_sort Chang, Ching-Hsin
collection PubMed
description BACKGROUND: Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). METHODS: We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student’s t-test and analysis of variance. RESULTS: The ages (mean ± SD) of the patients were 76.1 ± 9.4 and 72.6 ± 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 ± 5.0 and 6.5 ± 3.8, respectively, in the ThuVEP group and 18.2 ± 4.5 and 6.2 ± 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. CONCLUSIONS: One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients. TRIAL REGISTRATION: ISRCTN registry with study ID ISRCTN52339705. Date assigned: 06/03/2015.
format Online
Article
Text
id pubmed-4438483
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44384832015-05-21 Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study Chang, Ching-Hsin Lin, Tzu-Ping Chang, Yen-Hwa Huang, William JS Lin, Alex TL Chen, Kuang-Kuo BMC Urol Research Article BACKGROUND: Prostate vaporization and enucleation is a novel treatment option for bladder outlet obstruction caused by benign prostate enlargement. This surgical technique, however, has not yet been standardized. We present our findings of using a high-power thulium laser to accomplish vapoenucleation of the prostate (ThuVEP). METHODS: We prospectively collected and analyzed data from 29 patients who underwent ThuVEP between August 2010 and May 2012. The control group included 30 patients who underwent traditional transurethral resection of the prostate (TURP). Operative variables, patient profiles, preoperative and postoperative urine flow rates, prostate volume (measured using transrectal ultrasonography), and the international prostate symptom score (IPSS) were recorded and analyzed using a two-tailed Student’s t-test and analysis of variance. RESULTS: The ages (mean ± SD) of the patients were 76.1 ± 9.4 and 72.6 ± 7.4 years (p = 0.28) in the ThuVEP and TURP groups, respectively. The average urinary flow rates before and 12 months after the operation (volume/maximum flow/average flow) were 243.3/10.5/5.0 and 302.8/17.6/9.4 (in mL, mL/s, mL/s, respectively) in the ThuVEP group and 247.2/10.8/4.6 and 369.9/20.8/12.0, respectively, in the TURP group. Preoperative and postoperative IPSSs were 17.1 ± 5.0 and 6.5 ± 3.8, respectively, in the ThuVEP group and 18.2 ± 4.5 and 6.2 ± 3.3, respectively, in the TURP group. The mean ratio of the estimated postoperative residual prostate volume to the preoperative total volume was 0.47 (p = 0.449) in both groups. The overall complication rate was 20.7% in the ThuVEP group and 30.0% in the TURP group. CONCLUSIONS: One year of follow-up showed that ThuVEP and TURP effectively alleviated subjective and objective voiding symptoms with a low rate of complications. Thus, vapoenucleation using a high-power laser is feasible in elderly patients. TRIAL REGISTRATION: ISRCTN registry with study ID ISRCTN52339705. Date assigned: 06/03/2015. BioMed Central 2015-05-09 /pmc/articles/PMC4438483/ /pubmed/25956819 http://dx.doi.org/10.1186/s12894-015-0032-7 Text en © Chang et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chang, Ching-Hsin
Lin, Tzu-Ping
Chang, Yen-Hwa
Huang, William JS
Lin, Alex TL
Chen, Kuang-Kuo
Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title_full Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title_fullStr Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title_full_unstemmed Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title_short Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
title_sort vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438483/
https://www.ncbi.nlm.nih.gov/pubmed/25956819
http://dx.doi.org/10.1186/s12894-015-0032-7
work_keys_str_mv AT changchinghsin vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy
AT lintzuping vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy
AT changyenhwa vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy
AT huangwilliamjs vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy
AT linalextl vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy
AT chenkuangkuo vapoenucleationoftheprostateusingahighpowerthuliumlaseraoneyearfollowupstudy